EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating Endocannabinoids in Canine Cutaneous Mast Cell Tumor

Valentina Rinaldi iD, Fabiana Piscitelli iD, Andrea Boari iD, Roberta Verde iD, Paolo Emidio Crisi iD, Tiziana Bisogno iD

Animals · 16.10.2024 · 14 (20) · 2986

DOI: 10.3390/ani14202986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animals, online erschienen am 16.10.2024. Verfasst von Valentina Rinaldi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine, Veterinary Teaching Hospital, University of Teramo, 64100 Teramo, Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A cutaneous mast cell tumor (cMCT) is among the most common tumors in dogs. Endocannabinoids (eCBs) belong to the endocannabinoid system (ECS), which involves also cannabinoid receptors and an enzymatic system of biosynthesis and degradation. In this study, plasma levels of N-arachidonoylethanolamine (AEA), 2-arachidonoylglycerol (2-AG), N-palmitoylethanolamine (PEA), and N-oleoylethanolamine (OEA) were evaluated in 17 dogs with MCTs of varying histological grades and clinical stages, as well as in a control group of 11 dogs. Dogs affected by cMCT had higher plasma levels of 2-AG (p = 0.0001) and lower levels of AEA (p = 0.0012) and PEA (p = 0.0075) compared to the control group, while no differences were observed at the OEA level between healthy and cMCT dogs (p = 0.9264). The ability of eCBs to help discriminate between healthy and cMCT dogs was interrogated through the area under the ROC curve (AUC). An accuracy of 0.98 (95% confidence interval [CI], 0.94–1.02) was found for 2-AG, of 0.85 (95% CI, 0.71–0.99) for AEA, and of 0.81% for PEA (95% CI, 0.64–0.69). Values > 52.75 pmol/mL for 2-AG showed 94% sensitivity and 90% specificity in distinguishing cMCT. This is the first study to demonstrate alterations in plasmatic levels of eCBs in dogs affected by MCTs, suggesting the significance of these biomarkers in the tumorigenic process and their potential use as biomarkers in the future.

Schlagwörter

Stichwörter der Autor:innen

MCTdogendocannabinoidtumor

Autor:innen und Institutionen

  • Department of Veterinary Medicine, Veterinary Teaching Hospital, University of Teramo, 64100 Teramo, Italy.
  • Institute of Biomolecular Chemistry (ICB)-CNR, 34, 80078 Pozzuoli, Italy.
  • Institute of Translational Pharmacology (IFT)-CNR, Via Fosso del Cavaliere 100, 00133 Rome, Italy.

ORCID-Profile: Valentina Rinaldi, Fabiana Piscitelli, Andrea Boari, Roberta Verde, Paolo Emidio Crisi, Tiziana Bisogno

Zitieren

APA

Rinaldi, V., Piscitelli, F., Boari, A., Verde, R., Crisi, P. E., & Bisogno, T. (2024). Circulating Endocannabinoids in Canine Cutaneous Mast Cell Tumor. Animals, 14(20), 2986. https://doi.org/10.3390/ani14202986

Vancouver

Rinaldi V, Piscitelli F, Boari A, Verde R, Crisi PE, Bisogno T. Circulating Endocannabinoids in Canine Cutaneous Mast Cell Tumor. Animals. 2024;14(20):2986. doi:10.3390/ani14202986

BibTeX
@article{Rinaldi2024,
  author = {Rinaldi, Valentina and Piscitelli, Fabiana and Boari, Andrea and Verde, Roberta and Crisi, Paolo Emidio and Bisogno, Tiziana},
  title = {Circulating Endocannabinoids in Canine Cutaneous Mast Cell Tumor},
  journal = {Animals},
  year = {2024},
  volume = {14},
  number = {20},
  pages = {2986},
  doi = {10.3390/ani14202986}
}
Kostenlos starten →